Actualités

A single report on Chinese memory chip makers sent Micron tumbling and pulled Intel, AMD, and Marvell down with it, raising a question traders need to answer fast: is this a sector-wide buying opportunity or the start of something bigger?

The Bitcoin treasury giant will issue fresh preferred stock and resume buying once its Stretch shares climb back to par, CEO Phong Le said.

All three major US stock indexes were up in late-morning trading Wednesday, as technology stocks led

A fresh Morgan Stanley analysis just upended the thesis that sent neocloud stocks spiraling, and Nebius is responding with a business model shift that changes the growth math entirely.

Lucid confirms working with AlixPartners but calls bankruptcy rumors "completely false."

OpenAI says it sees no evidence supporting Apple's lawsuit over alleged trade-secret theft.

Dell has emerged as an unexpected beneficiary after IBM's results highlighted a growing enterprise shift toward AI infrastructure investments.

IBM stock ticked slightly lower Wednesday morning, following a brutal sell-off on Tuesday. Wall Street analysts were working to make sense of the results, which IBM Chief Executive Arvind Krishna acknowledged were "disappointing." IBM blamed an earnings and revenue miss on an AI-driven "capex reprioritization" that shifted enterprise tech spending toward hard-to-secure components like chips, memory and storage. Analysts with Oppenheimer downgraded IBM stock late Tuesday to a neutral "perform" rating from a prior outperform following the preannounced results.

OpenAI plans a screen-free AI home device while Apple seeks an injunction that could delay its rollout.

Lucid stock cratered 50% before staging a dramatic intraday reversal, but with a 31% Polymarket bankruptcy probability still lingering after the denial, traders are left wondering whether Wednesday's relief rally is a genuine turning point or just a dead cat bounce.

Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business. CEO Gail Boudreaux said the insurer’s Medicaid results were roughly what it expected, but the company is leaving the District of Columbia’s Medicaid market and plans to exit others over the next year to 18 months.

Shares closed just $1 above the IPO price as Wall Street remains broadly bullish despite continued selling pressure.

Billion-Dollar AI Deal Can't Save Nebius Stock as Meta Threat Looms

OpenAI still plans a year-end device reveal, but Apple's lawsuit, ecosystem strength and rising component costs may complicate its hardware push.

Quant ratings reveal relative strength across major competitors

Wells Fargo raised its Tesla stock target to $130 yet kept a sell, as record deliveries meet shrinking profit and a lofty valuation.

AMC cuts borrowing costs, extends a key debt maturity to 2031 and converts notes to equity, opening room for further interest savings.

NANO Nuclear Energy's microreactor prospects and low valuation support upside, but execution and regulatory risks loom.

Circle Internet Group has been under pressure, with the stock down 67.6% over the past year, and the current valuation checks point to a company that does not screen as a clear bargain despite recent regulatory wins and business developments. Over the last 12 months, Circle Internet Group shares have fallen 67.6%. This sets the bar low for any case that the current price already reflects the risks. Regulatory approvals such as the OCC trust bank charter and MiCA compliance can support...

The judge ruled that federal law protects Apple from claims tied to content uploaded by users.

Memory stocks are pulling back sharply Wednesday morning as traders lock in gains after a parabolic run. SK Hynix‘s (NASDAQ:SKHY) U.S.-listed ADR is down 5% to $184.50 in early trading, giving back a chunk of yesterday’s 27% surge to $193.92. The reversal is rippling through the group. Micron Technology (NASDAQ:MU) shares are off 3% to ... SK Hynix Drops 5%, SanDisk Slides 6%, Western Digital Slips 4% as Traders Take Profits in Memory Stocks

The denial of a delay is notable. Any credible delay in Vera Rubin's ramp would sharpen competitive pressure from AMD's advancing MI350 and MI400 roadmap, making the CEO's on-record rebuttal particularly consequential for investors who have priced Nvidia's product cycle into its elevated valuation.

Nebius said it has already signed initial agreements under the new structure and expects to generate revenue through licensing, commissions, revenue-sharing, and committed-capacity contracts.

Two bombshell reports from the Times and the Wall Street Journal suggest the American auto industry is running out of time, yet the real threat to Ford may not be Chinese EVs at all.

Crypto treasury firm Strategy (NASDAQ: $MSTR) says it should remain “very secure” unless Bitcoin’...

An EV blog reported Lucid was weighing Chapter 11 or going private on the advice of AlixPartners — Lucid called the claims false

The S&P 500 hasn't notched a new high since early June.

Gold was steady early on Wednesday as the dollar and treasury yields fell after the US reported an u

General Motors (NYSE:GM) is losing U.S. market share in the growing hybrid vehicle segment due to limited fuel-efficient offerings. Toyota is on track to overtake GM as the top-selling U.S. automaker by year-end, marking a potential shift in industry leadership. GM now plans to reintroduce plug-in hybrids in North America by 2027 after previously stepping away from this market. General Motors sits at the center of a major reshuffle in the U.S. auto industry as hybrid vehicle sales gain...

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.